Improvement of Cardiac Function by a Cardiac Myosin Activator in Conscious Dogs With Systolic Heart Failure-Reference-Cited by-同舟云学术

Improvement of Cardiac Function by a Cardiac Myosin Activator in Conscious Dogs With Systolic Heart Failure

Published:2010-07 Issue:4 Volume:3 Page:522-527
ISSN:1941-3289
Container-title:Circulation: Heart Failure
language:en
Short-container-title:Circ Heart Fail

Author:

Shen You-Tang¹,Malik Fady I.¹,Zhao Xin¹,Depre Christophe¹,Dhar Sunil K.¹,Abarzúa Patricio¹,Morgans David J.¹,Vatner Stephen F.¹

Affiliation:

1. From CV Dynamics, Inc (Y.-T.S., P.A., S.F.V.), North Brunswick, NJ; Cytokinetics, Inc (F.I.M., D.J.M.), South San Francisco, Calif; the Department of Cell Biology and Molecular Medicine and Cardiovascular Research Institute (Y.-T.S., X.Z., C.D., S.F.V.), New Jersey Medical School, UMDNJ, Newark, NJ; and the Department of Mathematical Sciences (S.K.D.), New Jersey Institute of Technology, Newark, NJ.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy

2. A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous electromechanical monitoring in engineered heart tissues using a mesoscale framework;Science Advances;2024-09-13

2. Efficacy and Safety of Omecamtiv Mecarbil in Adult Patients with Heart Failure with Reduced Ejection Fraction;International Journal of Pharmacology;2024-08-01

3. Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction;Nature Communications;2024-06-07

4. Beyond Quadruple Therapy and Current Therapeutic Strategies in Heart Failure with Reduced Ejection Fraction: Medical Therapies with Potential to Become Part of the Therapeutic Armamentarium;International Journal of Molecular Sciences;2024-03-07

5. Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite antagonistic effects in heart contraction;2023-11-15